SCHEMBL364905

SCHEMBL364905

CC(N1CCCCC1)C(O)(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 8/20 0.50
KCNH2 Q12809 8/20 0.49
CYP2D6 P10635 8/20 0.48
CYP2C19 P33261 6/20 0.48
CYP3A4 P08684 5/20 0.48
CYP2B6 P20813 1/20 0.46
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 2/20 0.44
CYP1A2 P05177 3/20 0.44
CYP2C9 P11712 3/20 0.44
KCNE1 P15382 1/20 0.44
CHRM2 P08172 2/20 0.44
HTR1A P08908 2/20 0.44
CHRM1 P11229 2/20 0.44
OPRM1 P35372 2/20 0.44
LMNA P02545 1/20 0.44
HSD17B10 Q99714 1/20 0.42
CHRM4 P08173 1/20 0.41
CHRM5 P08912 1/20 0.41
DRD2 P14416 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12890839 0.91 KCNA5 (0.52) KCNA5KCNH2CYP2D6CYP2C19CYP3A4
SCHEMBL12890842 0.89 KCNA5 (0.51) KCNA5KCNH2CYP2D6CYP2C19CYP3A4
SCHEMBL11258069 0.81 KCNA5 (0.39) KCNA5KCNH2CYP2D6CYP2C19CYP3A4
SCHEMBL480998 0.79 KCNA5 (0.73) KCNA5KCNH2CYP2D6CYP2C19CYP3A4
SCHEMBL480997 0.79 KCNA5 (0.73) KCNA5KCNH2CYP2D6CYP2C19CYP3A4
SCHEMBL12587918 0.79 KCNA5 (0.73) KCNA5KCNH2CYP2D6CYP2C19CYP3A4
SCHEMBL5541536 0.79 KCNA5 (0.73) KCNA5KCNH2CYP2D6CYP2C19CYP3A4
SCHEMBL11259609 0.78 MEN1 (0.41) KCNA5KCNH2CYP2D6CYP2C19CYP3A4
SCHEMBL11260709 0.77 KCNA5 (0.36) KCNA5KCNH2CYP2D6CYP2C19CYP3A4
SCHEMBL11872082 0.77 CYP2D6 (0.45) KCNA5KCNH2CYP2D6CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1294519-A Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient INPHARMA SA (CH) 2001-05-09 CN claimed
EP-1073470-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2001-02-07 EP claimed
WO-2000048636-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2000-08-24 WO claimed
US-20200197310-A1 Technology for Preparation of Macromolecular Microspheres NEXBIO, INC. 2020-06-25 US disclosed
US-10583086-B2 Technology for preparation of macromolecular microspheres ANSUN BIOPHARMA, INC. (US) 2020-03-10 US disclosed
US-20180071219-A1 Technology for Preparation of Macromolecular Microspheres NEXBIO, INC. 2018-03-15 US disclosed
US-20180028449-A1 Technology for the Preparation of Microparticles NEXBIO, INC. 2018-02-01 US disclosed
EP-2806034-B1 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject ROUSSY INST GUSTAVE (FR) 2017-06-28 EP disclosed
US-9682043-B2 Method of preparation of mixed phase co-crystals with active agents MEDCRYSTALFORMS, LLC (US) 2017-06-20 US disclosed
US-20170079920-A1 Technology for the Preparation of Microparticles NEXBIO, INC. 2017-03-23 US disclosed
US-20160235675-A1 Technology for the Preparation of Microparticles NEXBIO, INC. 2016-08-18 US disclosed
CN-1178699-C Pharmaceutical Compsns. contg. compounds with activity for enhancement of absorption of active ingredients 2004-12-08 CN disclosed
US-20040018241-A1 Bioadhesive compositions and methods for topical administration of active agents NOVEN PHARMACEUTICALS, INC. 2004-01-29 US disclosed
US-6562363-B1 Bioadhesive compositions and methods for topical administration of active agents NOVEN PHARMACEUTICALS, INC. 2003-05-13 US disclosed
CN-1294519-A Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient INPHARMA SA (CH) 2001-05-09 CN disclosed
US-6221383-B1 BLEND OF AT LEAST TWO POLYMERS, OR AT LEAST ONE POLYMER AND A SOLUBLE POLYVINYLPYRROLIDONE, IN COMBINATION WITH A DRUG PROVIDES A PRESSURE-SENSITIVE ADHESIVE COMPOSITION FOR A TRANSDERMAL DRUG DELIVERY SYSTEM NOVEN PHARMACEUTICALS, INC. 2001-04-24 US disclosed
US-6024976-A TRANSDERMAL DRUG DELIVERY WITH PRESSURE SENSITIVE ADHESIVE COMPOSITION OF POLYVINYLPYRROLIDONE WITH DRUG IN MULTILAYER PATCH NOVEN PHARMACEUTICALS, INC. (US) 2000-02-15 US disclosed
US-5719197-A DRUG DELIVERY NOVEN PHARMACEUTICALS, INC. (US) 1998-02-17 US disclosed
US-5656286-A BLEND OF TWO POLYMERS; PRESSURE SENSITIVE ADHESIVE NOVEN PHARMACEUTICALS, INC. (US) 1997-08-12 US disclosed
US-5446070-A Flexible, finite, bioadhesive, therapeutical agent in solid form NOVER PHARMACEUTICALS, INC. (US) 1995-08-29 US disclosed